Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
JAIC America, Inc. is the U.S.-based venture capital subsidiary of Japan Asia Investment Co., Ltd. (JAIC), one of Japan's leading independent investment firms. Headquartered in Palo Alto, California, the company focuses on identifying and investing in high-growth North American startups within the life sciences, biotechnology, and information technology sectors. JAIC America serves as a strategic bridge, helping its portfolio companies navigate the complexities of the Japanese market and establish partnerships with major Japanese corporations. The firm provides both financial capital and extensive business development support, leveraging its parent company's deep network in the Asian business community to facilitate licensing and distribution deals. Their investment history includes innovative companies in drug discovery, medical devices, and regenerative medicine.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on JAIC America.